BetterLife Pharma Inc.
جودة البيانات: 67%
BETRF
OTC
Manufacturing
Chemicals
KWD 0.04
▼
KWD 0.01
(-15.69%)
القيمة السوقية: 6.53 M
السعر
KWD 0.04
القيمة السوقية
6.53 M
نطاق اليوم
KWD 0.04 — KWD 0.04
نطاق 52 أسبوعًا
KWD 0.03 — KWD 0.09
حجم التداول
2,500
فتح KWD 0.04
متوسط 50 يوم / 200 يوم
KWD 0.05
5.49% below
متوسط 50 يوم / 200 يوم
KWD 0.05
15.85% below
Quick Summary
النقاط الرئيسية
Negative free cash flow of -5.63 M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
N/A
Current Ratio0.15
Interest CoverageN/A
التقييم
P/E Ratio
N/A
P/B Ratio1.90
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1364 نظير)
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1364 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | — | -1.5 |
| P/B | 1.9 | 1.6 |
| ROE % | — | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | N/A |
| ROE | N/A | ROA | N/A |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -5.63 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.15 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -3.09 M | Tangible Book Value | -3.09 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | N/A | Forward P/E | N/A |
| P/B Ratio | 1.90 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -86.17% | ||
| Market Cap | 6.53 M | Enterprise Value | 6.12 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -0.04 | OCF / Share | -0.04 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | N/A |
| SBC-Adj. FCF | -5.63 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | — | -121,182.0 | -6.28 M | -8.58 M | — |
| EPS (Diluted) | — | — | — | -0.11 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | -1.05 M | -6.02 M | -8.59 M | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | 70,304.0 | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | 322.0 | 322.0 | — |
| Interest Expense | — | 27,385.0 | 11,661.0 | 64,888.0 | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2018 | FY2017 | FY2016 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Total Assets | 383,817.0 | 132,658.0 | 106,115.0 | 3,844.0 | 3,844.0 |
| Total Liabilities | 429,200.0 | — | 435,104.0 | 1.03 M | 1.03 M |
| Shareholders' Equity | -45,383.0 | -1.47 M | -328,989.0 | -1.02 M | -1.02 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 64,511.0 | 112,421.0 | 71,639.0 | 2,061.0 | 15,037.0 |
| Current Assets | 149,253.0 | 129,758.0 | 103,215.0 | 2,061.0 | 2,061.0 |
| Current Liabilities | — | 1.61 M | — | 866,265.0 | 866,265.0 |
{"event":"ticker_viewed","properties":{"ticker":"BETRF","listing_kind":"stock","pathname":"/stocks/betrf","exchange":"OTC","country":"US"}}